Accession ID: MIRT003898 [miRNA, hsa-miR-17 ::
APP, target gene]
| pre-miRNA ID | hsa-mir-17 LinkOut: [miRBase ] |
|---|---|
| Synonyms | MIR91, MIRN17, MIRN91, hsa-mir-17, miR-17, miR17-3p, miRNA17, MIR17 |
| Description | Homo sapiens miR-17 stem-loop |
| 2nd Structure of pre-miRNA | ![]() |
| Mature miRNA | hsa-miR-17-3p |
|---|---|
| Mature Sequence | 51| ACUGCAGUGAAGGCACUUGUAG |72 |
| Evidence | Experimental |
| Experiments | Cloned |
| Expression Profile | ![]() |
| Putative hsa-miR-17-3p Targets | LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ] |
| Mature miRNA | hsa-miR-17-5p |
| Mature Sequence | 14| CAAAGUGCUUACAGUGCAGGUAG |36 |
| Evidence | Experimental |
| Experiments | Cloned |
| Expression Profile | ![]() |
| Putative hsa-miR-17-5p Targets | LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ] |
![]() |
| Gene Symbol | APP LinkOut: [ Entrez Gene | BioGPS | Wikipedia | iHop ] | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2 | ||||||||||||||||||||
| Description | amyloid beta (A4) precursor protein | ||||||||||||||||||||
| Transcript | NM_000484 LinkOut: [ RefSeq ] | ||||||||||||||||||||
| Other Transcripts | NM_001136129, NM_001136130, NM_201413, NM_201414 | ||||||||||||||||||||
| Expression | LinkOut: [ BioGPS ] | ||||||||||||||||||||
| KEGG Pathway |
hsa05010 Alzheimer's disease - Homo sapiens (human) |
||||||||||||||||||||
| Putative miRNA Targets on APP | LinkOut: [ TargetScan 5.1 | MicroCosm | miRNAMap 2.0 ] | ||||||||||||||||||||
| 3'UTR of APP (miRNA target sites are highlighted) |
>APP|NM_000484|3'UTR 1 TAGACCCCCGCCACAGCAGCCTCTGAAGTTGGACAGCAAAACCATTGCTTCACTACCCATCGGTGTCCATTTATAGAATA 81 ATGTGGGAAGAAACAAACCCGTTTTATGATTTACTCATTATCGCCTTTTGACAGCTGTGCTGTAACACAAGTAGATGCCT 161 GAACTTGAATTAATCCACACATCAGTAATGTATTCTATCTCTCTTTACATTTTGGTCTCTATACTACATTATTAATGGGT 241 TTTGTGTACTGTAAAGAATTTAGCTGTATCAAACTAGTGCATGAATAGATTCTCTCCTGATTATTTATCACATAGCCCCT 321 TAGCCAGTTGTATATTATTCTTGTGGTTTGTGACCCAATTAAGTCCTACTTTACATATGCTTTAAGAATCGATGGGGGAT 401 GCTTCATGTGAACGTGGGAGTTCAGCTGCTTCTCTTGCCTAAGTATTCCTTTCCTGATCACTATGCATTTTAAAGTTAAA 481 CATTTTTAAGTATTTCAGATGCTTTAGAGAGATTTTTTTTCCATGACTGCATTTTACTGTACAGATTGCTGCTTCTGCTA 561 TATTTGTGATATAGGAATTAAGAGGATACACACGTTTGTTTCTTCGTGCCTGTTTTATGTGCACACATTAGGCATTGAGA 641 CTTCAAGCTTTTCTTTTTTTGTCCACGTATCTTTGGGTCTTTGATAAAGAAAAGAATCCCTGTTCATTGTAAGCACTTTT 721 ACGGGGCGGGTGGGGAGGGGTGCTCTGCTGGTCTTCAATTACCAAGAATTCTCCAAAACAATTTTCTGCAGGATGATTGT 801 ACAGAATCATTGCTTATGACATGATCGCTTTCTACACTGTATTACATAAATAAATTAAATAAAATAACCCCGGGCAAGAC 881 TTTTCTTTGAAGGATGACTACAGACATTAAATAATCGAAGTAATTTTGGGTGGGGAGAAGAGGCAGATTCAATTTTCTTT 961 AACCAGTCTGAAGTTTCATTTATGATACAAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGGATGAGGAAGGCATGCC 1041 TGGACAAACCCTTCTTTTAAGATGTGTCTTCAATTTGTATAAAATGGTGTTTTCATGTAAATAAATACATTCTTGGAGGA 1121 GCAAAAAAAAAAAAAAAA Target sites Provided by authors Predicted by miRanda |
||||||||||||||||||||
| miRNA-target interactions (Predicted by miRanda) |
|
| miRNA:Target | hsa-miR-17 :: APP [ Functional MTI ] |
|---|---|
| Validation Method | Luciferase reporter assay , Western blot |
| Conditions | HeLa |
| Location of target site | 3'UTR |
| Tools used in this research | miRanda, miRBase Target Database, PicTar, TargetScan |
| Original Description (Extracted from the article) | ... We found that miR-20a, miR-17-5p, and miRNA106b affected significantly luciferase expression (Fig. 1B).//We transfected complementary anti-miR oligonucleotides and these caused a sig- nificant increase in luciferase expression (Fig. 1F). Thus we identify three miRNAs that bind directly and specifically to the 3′UTR of APP. ... - Hebert, S. S. Horre, K. Nicolai, L. et al., 2009, Neurobiol Dis. |
| Article |
- Hebert, S. S.
Horre, K.
Nicolai, L. et al. - Neurobiol Dis, 2009
Gene dosage effects of Amyloid precursor protein (APP) can cause familial AD. Recent evidence suggest that microRNA (miRNA) pathways, implicated in gene transcriptional control, could be involved in the development of sporadic Alzheimer's disease (AD). We therefore investigated whether miRNAs could participate in the regulation of APP gene expression. We show that miRNAs belonging to the miR-20a family (that is, miR-20a, miR-17-5p and miR-106b) could regulate APP expression in vitro and at the endogenous level in neuronal cell lines. A tight correlation between these miRNAs and APP was found during brain development and in differentiating neurons. We thus identify miRNAs as novel endogenous regulators of APP expression, suggesting that variations in miRNA expression could contribute to changes in APP expression in the brain during development and disease. This possibility is further corroborated by the observation that a statistically significant decrease in miR-106b expression was found in sporadic AD patients.
LinkOut: [PMID: 19110058]
|



